홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
IMCR
#2134
Immunocore Holdings plc American Depositary Shares
31.640
0
USD
-0.16%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-0.16%
월간 변동
+3.06%
6달 변화
-5.50%
년간 변동율
-5.50%
이전 종가
31.690
0
Open
31.640
0
Bid
Ask
Low
31.640
0
High
31.640
0
양
29
마켓
주식
헬스케어
IMCR
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Total assets
1.01 B
1.03 B
1.08 B
1.1 B
1.07 B
Total liabilities
648.79 M
649.53 M
693.91 M
705.94 M
686.24 M
Total equity
360.72 M
378.48 M
388.48 M
396.56 M
381.03 M
Total liabilities & shareholders' equities
1.01 B
1.03 B
1.08 B
1.1 B
1.07 B
Total debt
391.01 M
391.53 M
392.06 M
392.59 M
393.13 M
Net debt
-429.36 M
-445.5 M
-490.75 M
-499.77 M
-471.03 M
Immunocore Holdings plc - American Depositary Shares
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
뉴스
Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma
제퍼리스, 이뮤노코어 투자의견 하향…매출 우려
Jefferies downgrades Immunocore stock rating on revenue concerns
Immunocore, 전략적 성장 및 혁신 발표
Immunocore at Leerink Conference: Strategic Growth and Innovation
Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript
이뮤노코어 홀딩스 Q4 실적, 수익 에상치보다 저조
Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates
JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y